Sony Biotechnology Inc.
About Sony Biotechnology Inc.
Sony Biotechnology Inc. is a subsidiary of Sony Group Corporation, focused on flow cytometry and spectral imaging technologies for biological research and clinical applications. Founded in 1995 and based in San Jose, California, the company has a global presence with offices in Japan, China, and Europe, as well as distributors worldwide. With around 156 employees, Sony Biotechnology generates annual revenue of $22.3 million and is part of Sony's strategy to diversify into high-tech medical and scientific equipment.
The company offers a range of flow cytometry and imaging instrumentation, reagents, and services that support life science discovery. Their products are essential in areas like immunology, cancer research, and drug development. Notable instruments include the FP7000 Spectral Cell Sorter, ID7000 Spectral Cell Analyzer, and CGX10 Cell Isolation System. Sony Biotechnology also utilizes advanced technologies such as spectral analysis and low-noise electronics to enhance the accuracy and efficiency of their solutions. Their innovations have earned them several awards, highlighting their commitment to advancing scientific research.